Keller, Michael D. http://orcid.org/0000-0001-8323-3085
Hanley, Patrick J.
Chi, Yueh-Yun
Aguayo-Hiraldo, Paibel http://orcid.org/0000-0002-0196-806X
Dvorak, Christopher C. http://orcid.org/0000-0002-6146-3952
Verneris, Michael R.
Kohn, Donald B.
Pai, Sung-Yun http://orcid.org/0000-0002-0158-8147
Dávila Saldaña, Blachy J.
Hanisch, Benjamin
Quigg, Troy C. http://orcid.org/0000-0002-5268-7938
Adams, Roberta H.
Dahlberg, Ann
Chandrakasan, Shanmuganathan http://orcid.org/0000-0001-8007-9932
Hasan, Hasibul
Malvar, Jemily
Jensen-Wachspress, Mariah A.
Lazarski, Christopher A. http://orcid.org/0000-0001-8917-7280
Sani, Gelina
Idso, John M.
Lang, Haili
Chansky, Pamela http://orcid.org/0000-0002-8169-992X
McCann, Chase D.
Tanna, Jay
Abraham, Allistair A.
Webb, Jennifer L.
Shibli, Abeer
Keating, Amy K.
Satwani, Prakash
Muranski, Pawel
Hall, Erin
Eckrich, Michael J.
Shereck, Evan
Miller, Holly
Mamcarz, Ewelina
Agarwal, Rajni
De Oliveira, Satiro N. http://orcid.org/0000-0002-8181-7316
Vander Lugt, Mark T.
Ebens, Christen L.
Aquino, Victor M.
Bednarski, Jeffrey J. http://orcid.org/0000-0001-6902-0876
Chu, Julia http://orcid.org/0009-0000-2710-7244
Parikh, Suhag
Whangbo, Jennifer
Lionakis, Michail http://orcid.org/0000-0003-4994-9500
Zambidis, Elias T.
Gourdine, Elizabeth
Bollard, Catherine M. http://orcid.org/0000-0001-5140-9090
Pulsipher, Michael A.
Funding for this research was provided by:
California Institute for Regenerative Medicine (CLIN2-10392)
Article History
Received: 5 August 2023
Accepted: 19 March 2024
First Online: 18 April 2024
Competing interests
: C.M.B. has filed patents in the arena of cell therapies, was a scientific co-founder of Mana Therapeutics and Catamaran Bio, is on the Board of Directors of Cabaletta Bio and holds stock in Repertoire Immune Medicine and Neximmune all of which are developing cell therapies for cancer or immune mediated disorders. In addition, she serves on the drug safety monitoring boards (DSMB) for SOBI and on the SAB of Minovia TX Ltd. M.A.P. is on Advisory boards—Novartis, Gentibio, Bluebird, Vertex, Medexus, Equillium; and Study Support—Adaptive, Miltenyi. P.J.H. was a Co-founder and Board of Directors: Mana Therapeutics and is on the Scientific Advisory Boards for Cellevolve, Cellenkos, Capsida, MicrofluidX, Discovery Life Sciences M.R.V. is on the Ad boards for Qihan, Sanofi, the Adjudication board for Allovir, and DSMBs for Forge and Omeros. P.S. is a consultant for Sobi BJD is an Ad hoc consultant for Sobi and on the DSMB for Orchard Therapeutics S.C. is an Ad hoc advisory board member of Pharming, SOBI, X4 therapeutics and Electra therapeutics T.C.Q. is on the speakers bureau for Jazz Pharmaceuticals and Alexion Pharmaceuticals. C.C.D. is a consultant for Alexion Pharmaceuticals and Jazz Pharmaceuticals. M.D.K. is an author for Elsevier (Uptodate). All other authors have no competing interests to disclose.